iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Gland Pharma stock price down by more than 4% today

30 Nov 2022 , 02:50 PM

Following the company’s entry into a Put Option Agreement to purchase 100% of Cenexi Group for an equity value not exceeding Euro 120 million on Wednesday, Gland Pharma’s shares fell 5% to Rs 1,787.55 on the BSE (Enterprise Value of Euro 230 million).
Through its wholly-owned Singaporean subsidiary Gland Pharma International PTE. Ltd., Gland Pharma will purchase Cenexi Group. Cenexi reported yearly sales of 184.1 million euros in CY21 and an Ebitda of 23.1 million euros; in H1CY22, the exact figures were 100.1 million euros and 19.1 million euros, respectively. Earnings Before Interest, Tax, Depreciation, and Amortization, or Ebitda, is what is referred to.
In the last three months, Gland Pharma’s stock price has decreased by 25%, while the S&P BSE Sensex has increased by 5.4%. Furthermore, it has lost 50% of its value in the last year compared to the benchmark index’s 10% rally. On November 10, 2022, the stock dropped to an all-time low of Rs 1,660. On August 12, 2021, it reached its highest point of Rs 4,350.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • BSE
  • business
  • Buzzing Stocks
  • Cenexi
  • Company
  • Gland Pharma
  • India
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Indices end lower
21 Jun 2024|03:40 PM
Market Update: Nifty and Sensex Dip
21 Jun 2024|01:47 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.